Cargando…

Influence of Coping and Self-Efficacy in Inflammatory Bowel Disease

(1) Background: Coping includes the specific cognitive processes and behaviours that the patient uses when faced with the stress of living with a chronic disease. Self-efficacy is the knowledge that individuals have about their abilities and their confidence to face a problem or cope with a situatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Muñoz González, Estela, Durantez-Fernández, Carlos, Pérez-Pérez, Lucía, de Dios-Duarte, María José
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10138294/
https://www.ncbi.nlm.nih.gov/pubmed/37107947
http://dx.doi.org/10.3390/healthcare11081113
_version_ 1785032672858341376
author Muñoz González, Estela
Durantez-Fernández, Carlos
Pérez-Pérez, Lucía
de Dios-Duarte, María José
author_facet Muñoz González, Estela
Durantez-Fernández, Carlos
Pérez-Pérez, Lucía
de Dios-Duarte, María José
author_sort Muñoz González, Estela
collection PubMed
description (1) Background: Coping includes the specific cognitive processes and behaviours that the patient uses when faced with the stress of living with a chronic disease. Self-efficacy is the knowledge that individuals have about their abilities and their confidence to face a problem or cope with a situation (disease). The aim of this study was to explore the role of coping and self-efficacy in inflammatory bowel disease. (2) Materials and Methods: A total of 92 participants were included (33 had been diagnosed with Crohn’s disease, 23 with ulcerative colitis and 36 were healthy participants). The Coping Strategies Inventory was used to measure which coping strategies were employed, differentiating them as active or passive. The General Self-Efficacy Scale was used to measure self-efficacy. (3) Results: The results indicate that people with inflammatory bowel disease used strategies related to passive coping more than healthy people (mean of 36.39 ± 13.92 vs. 29.77 ± 10.70, p = 0.017). Additionally, people with inflammatory bowel disease used social withdrawal more than healthy participants (mean of 8.30 ± 5.07 vs. 4.47 ± 4.17, p < 0.001). In addition, there are significant differences in emotion-focused engagement coping strategies. People with inflammatory bowel disease used this strategy less than healthy people (mean of 21.77 ± 7.75 vs. 25.03 ± 7.00, p = 0.044). Finally, healthy participants used the emotion-focused disengagement strategy less than those diagnosed with inflammatory bowel disease (mean of 9.81 ± 7.74 vs. 15.61 ± 10.14, p = 0.004). (4) Conclusions: Actions aimed at the development of active coping strategies and patient socialisation must be included in the treatment of inflammatory bowel disease.
format Online
Article
Text
id pubmed-10138294
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-101382942023-04-28 Influence of Coping and Self-Efficacy in Inflammatory Bowel Disease Muñoz González, Estela Durantez-Fernández, Carlos Pérez-Pérez, Lucía de Dios-Duarte, María José Healthcare (Basel) Article (1) Background: Coping includes the specific cognitive processes and behaviours that the patient uses when faced with the stress of living with a chronic disease. Self-efficacy is the knowledge that individuals have about their abilities and their confidence to face a problem or cope with a situation (disease). The aim of this study was to explore the role of coping and self-efficacy in inflammatory bowel disease. (2) Materials and Methods: A total of 92 participants were included (33 had been diagnosed with Crohn’s disease, 23 with ulcerative colitis and 36 were healthy participants). The Coping Strategies Inventory was used to measure which coping strategies were employed, differentiating them as active or passive. The General Self-Efficacy Scale was used to measure self-efficacy. (3) Results: The results indicate that people with inflammatory bowel disease used strategies related to passive coping more than healthy people (mean of 36.39 ± 13.92 vs. 29.77 ± 10.70, p = 0.017). Additionally, people with inflammatory bowel disease used social withdrawal more than healthy participants (mean of 8.30 ± 5.07 vs. 4.47 ± 4.17, p < 0.001). In addition, there are significant differences in emotion-focused engagement coping strategies. People with inflammatory bowel disease used this strategy less than healthy people (mean of 21.77 ± 7.75 vs. 25.03 ± 7.00, p = 0.044). Finally, healthy participants used the emotion-focused disengagement strategy less than those diagnosed with inflammatory bowel disease (mean of 9.81 ± 7.74 vs. 15.61 ± 10.14, p = 0.004). (4) Conclusions: Actions aimed at the development of active coping strategies and patient socialisation must be included in the treatment of inflammatory bowel disease. MDPI 2023-04-13 /pmc/articles/PMC10138294/ /pubmed/37107947 http://dx.doi.org/10.3390/healthcare11081113 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Muñoz González, Estela
Durantez-Fernández, Carlos
Pérez-Pérez, Lucía
de Dios-Duarte, María José
Influence of Coping and Self-Efficacy in Inflammatory Bowel Disease
title Influence of Coping and Self-Efficacy in Inflammatory Bowel Disease
title_full Influence of Coping and Self-Efficacy in Inflammatory Bowel Disease
title_fullStr Influence of Coping and Self-Efficacy in Inflammatory Bowel Disease
title_full_unstemmed Influence of Coping and Self-Efficacy in Inflammatory Bowel Disease
title_short Influence of Coping and Self-Efficacy in Inflammatory Bowel Disease
title_sort influence of coping and self-efficacy in inflammatory bowel disease
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10138294/
https://www.ncbi.nlm.nih.gov/pubmed/37107947
http://dx.doi.org/10.3390/healthcare11081113
work_keys_str_mv AT munozgonzalezestela influenceofcopingandselfefficacyininflammatoryboweldisease
AT durantezfernandezcarlos influenceofcopingandselfefficacyininflammatoryboweldisease
AT perezperezlucia influenceofcopingandselfefficacyininflammatoryboweldisease
AT dediosduartemariajose influenceofcopingandselfefficacyininflammatoryboweldisease